Menu

Image of the Day: Un-break My Heart

A failing heart is easily distinguished from a healthy one by numerous tell-tale signs, including its slender, stretched-out walls, increased size, and pooled blood clots.

Aug 8, 2017
The Scientist Staff

Healthy (left) and failing (right) mouse hearts. A blood clot noticeably pools in the top right chamber of the failing heart.GRUETER LABORATORY, UNIVERSITY OF IOWA HEALTH CARE Researchers recently unearthed gene expression patterns in heart tissues from a mouse model of heart failure that were noticeable before the mice’s hearts began to show symptoms. These patterns mimicked those observed in diseased human heart cells.

“In terms of disease progression, heart failure is the end stage,” says senior author Chad Grueterin a news release. “Our study suggests that the transition, or ‘switch,’ from a stressed, enlarged heart to a failing heart is key. Looking ahead, hopefully we’ll be able to test whether a drug can block that switch from occurring.”

See D.D. Hall et al., “Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure,” JCI Insight2:e92476, 2017.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.